Cargando…

Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients

Background: The aim of this retrospective study was to investigate clinical and pathological characteristics of the tall cell variant of papillary thyroid carcinoma compared to conventional variants. Methods: The clinical records of patients who underwent surgical treatment between 2009 and 2015 wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Longheu, Alessandro, Canu, Gian Luigi, Cappellacci, Federico, Erdas, Enrico, Medas, Fabio, Calò, Pietro Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794904/
https://www.ncbi.nlm.nih.gov/pubmed/33379135
http://dx.doi.org/10.3390/jcm10010070
_version_ 1783634318274330624
author Longheu, Alessandro
Canu, Gian Luigi
Cappellacci, Federico
Erdas, Enrico
Medas, Fabio
Calò, Pietro Giorgio
author_facet Longheu, Alessandro
Canu, Gian Luigi
Cappellacci, Federico
Erdas, Enrico
Medas, Fabio
Calò, Pietro Giorgio
author_sort Longheu, Alessandro
collection PubMed
description Background: The aim of this retrospective study was to investigate clinical and pathological characteristics of the tall cell variant of papillary thyroid carcinoma compared to conventional variants. Methods: The clinical records of patients who underwent surgical treatment between 2009 and 2015 were analyzed. The patients were divided into two groups: those with a histopathological diagnosis of tall cell papillary carcinoma were included in Group A, and those with a diagnosis of conventional variants in Group B. Results: A total of 35 patients were included in Group A and 316 in Group B. All patients underwent total thyroidectomy. Central compartment and lateral cervical lymph node dissection were performed more frequently in Group A (42.8% vs. 18%, p = 0.001, and 17.1% vs. 6.9%, p = 0.04). Angiolymphatic invasion, parenchymal invasion, extrathyroidal extension, and lymph node metastases were more frequent in Group A, and the data reached statistical significance. Local recurrence was more frequent in Group A (17.1% vs. 6.3%, p = 0.02), with two patients (5.7%) in Group A showing visceral metastases, whereas no patient in Group B developed metastatic cancer (p = 0.009). Conclusions: Tall cell papillary carcinoma is the most frequent aggressive variant of papillary thyroid cancer. Tall cell histology represents an independent poor prognostic factor compared to conventional variants.
format Online
Article
Text
id pubmed-7794904
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77949042021-01-10 Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients Longheu, Alessandro Canu, Gian Luigi Cappellacci, Federico Erdas, Enrico Medas, Fabio Calò, Pietro Giorgio J Clin Med Article Background: The aim of this retrospective study was to investigate clinical and pathological characteristics of the tall cell variant of papillary thyroid carcinoma compared to conventional variants. Methods: The clinical records of patients who underwent surgical treatment between 2009 and 2015 were analyzed. The patients were divided into two groups: those with a histopathological diagnosis of tall cell papillary carcinoma were included in Group A, and those with a diagnosis of conventional variants in Group B. Results: A total of 35 patients were included in Group A and 316 in Group B. All patients underwent total thyroidectomy. Central compartment and lateral cervical lymph node dissection were performed more frequently in Group A (42.8% vs. 18%, p = 0.001, and 17.1% vs. 6.9%, p = 0.04). Angiolymphatic invasion, parenchymal invasion, extrathyroidal extension, and lymph node metastases were more frequent in Group A, and the data reached statistical significance. Local recurrence was more frequent in Group A (17.1% vs. 6.3%, p = 0.02), with two patients (5.7%) in Group A showing visceral metastases, whereas no patient in Group B developed metastatic cancer (p = 0.009). Conclusions: Tall cell papillary carcinoma is the most frequent aggressive variant of papillary thyroid cancer. Tall cell histology represents an independent poor prognostic factor compared to conventional variants. MDPI 2020-12-28 /pmc/articles/PMC7794904/ /pubmed/33379135 http://dx.doi.org/10.3390/jcm10010070 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Longheu, Alessandro
Canu, Gian Luigi
Cappellacci, Federico
Erdas, Enrico
Medas, Fabio
Calò, Pietro Giorgio
Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
title Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
title_full Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
title_fullStr Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
title_full_unstemmed Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
title_short Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
title_sort tall cell variant versus conventional papillary thyroid carcinoma: a retrospective analysis in 351 consecutive patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794904/
https://www.ncbi.nlm.nih.gov/pubmed/33379135
http://dx.doi.org/10.3390/jcm10010070
work_keys_str_mv AT longheualessandro tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients
AT canugianluigi tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients
AT cappellaccifederico tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients
AT erdasenrico tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients
AT medasfabio tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients
AT calopietrogiorgio tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients